ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 387 filers reported holding ENCOMPASS HEALTH CORP in Q2 2023. The put-call ratio across all filers is 2.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $308,844 | +3.9% | 3,600 | 0.0% | 0.01% | 0.0% |
Q1 2024 | $297,288 | +6.1% | 3,600 | -14.3% | 0.01% | 0.0% |
Q4 2023 | $280,224 | -0.7% | 4,200 | 0.0% | 0.01% | -14.3% |
Q3 2023 | $282,072 | -0.8% | 4,200 | 0.0% | 0.01% | 0.0% |
Q2 2023 | $284,382 | +125178.4% | 4,200 | 0.0% | 0.01% | +16.7% |
Q1 2023 | $227 | -9.6% | 4,200 | 0.0% | 0.01% | -14.3% |
Q4 2022 | $251 | -99.9% | 4,200 | 0.0% | 0.01% | 0.0% |
Q2 2022 | $235,000 | -24.9% | 4,200 | -4.5% | 0.01% | 0.0% |
Q1 2022 | $313,000 | -4.0% | 4,400 | -12.0% | 0.01% | 0.0% |
Q4 2021 | $326,000 | -18.1% | 5,000 | -5.7% | 0.01% | -30.0% |
Q3 2021 | $398,000 | -3.9% | 5,300 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $414,000 | -4.6% | 5,300 | 0.0% | 0.01% | -16.7% |
Q1 2021 | $434,000 | -12.5% | 5,300 | -11.7% | 0.01% | -14.3% |
Q4 2020 | $496,000 | +27.2% | 6,000 | 0.0% | 0.01% | +7.7% |
Q3 2020 | $390,000 | -3.2% | 6,000 | -7.7% | 0.01% | -13.3% |
Q2 2020 | $403,000 | -3.1% | 6,500 | 0.0% | 0.02% | -21.1% |
Q1 2020 | $416,000 | – | 6,500 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DARUMA CAPITAL MANAGEMENT LLC | 587,603 | $45,804,000 | 4.32% |
Kalos Management, Inc. | 77,043 | $6,000,000 | 3.22% |
MARIETTA INVESTMENT PARTNERS LLC | 101,122 | $7,882,000 | 2.34% |
Copeland Capital Management, LLC | 471,462 | $36,750,000 | 2.22% |
REINHART PARTNERS, LLC. | 278,916 | $21,742,000 | 1.97% |
Rock Springs Capital Management LP | 676,500 | $52,733,000 | 1.91% |
Wolf Group Capital Advisors | 35,599 | $2,775,000 | 1.81% |
GARRISON BRADFORD & ASSOCIATES INC | 27,608 | $2,152,000 | 1.73% |
BROADVIEW ADVISORS LLC | 123,907 | $9,659,000 | 1.65% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 70,000 | $5,457,000 | 1.64% |